RESUMEN
PURPOSE: The mononuclear phagocyte system (MPS) presents a formidable obstacle that hampers the delivery of various nanopreparations to tumors. Therefore, there is an urgent need to improve the off-MPS targeting ability of nanomedicines. In the present study, we present a novel preconditioning strategy to substantially increase the circulation times and tumor targeting of nanoparticles by regulating nanocarrier-MPS interactions. METHODS: In vitro, the effect of different vacuolar H+-ATPase inhibitors on macrophage uptake of targeted or nontargeted lipid vesicles was evaluated. Specifically, the clinically approved proton-pump inhibitor esomeprazole (ESO) was selected as a preconditioning agent. Then, we further investigated the blocking effect of ESO on the macrophage endocytosis of nanocarriers. In vivo, ESO was first intravenously administered into A549-tumor-bearing nude mice, and 24 h later, the c(RGDm7)-modified vesicles co-loaded with doxorubicin and gefitinib were intravenously injected. RESULTS: In vitro, ESO was found to reduce the interactions between macrophages and c(RGDm7)-modified vesicles by interfering with the latter's lysosomal trafficking. Studies conducted in vivo confirmed that ESO pretreatment greatly decreased the liver and spleen distribution of the targeted vesicles, enhanced their tumor accumulation, and improved the therapeutic outcome of the drug-loaded nanomedicines. CONCLUSION: Our findings indicate that ESO can regulate the nanoparticle-MPS interaction, which provides a feasible option for enhancing the off-MPS targeting of nanomedicines.
Asunto(s)
Portadores de Fármacos/química , Esomeprazol/farmacología , Sistema Mononuclear Fagocítico/citología , Nanopartículas/química , Células A549 , Animales , Antineoplásicos/farmacocinética , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Transporte Biológico , Muerte Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Doxorrubicina/farmacología , Endocitosis , Esomeprazol/farmacocinética , Esomeprazol/uso terapéutico , Humanos , Lisosomas/efectos de los fármacos , Lisosomas/metabolismo , Células MCF-7 , Ratones , Ratones Desnudos , Nanopartículas/administración & dosificación , Neoplasias/tratamiento farmacológico , Fosfatidiletanolaminas/química , Polietilenglicoles/química , Células RAW 264.7 , Distribución Tisular/efectos de los fármacos , ATPasas de Translocación de Protón Vacuolares/metabolismoRESUMEN
We have only recently started to appreciate the extent to which immune cell activation involves significant changes in cellular metabolism. We are now beginning to understand how commitment to specific metabolic pathways influences aspects of cellular biology that are the more usual focus of immunological studies, such as activation-induced changes in gene transcription, post-transcriptional regulation of transcription, post-translational modifications of proteins, cytokine secretion, etc. Here, we focus on metabolic reprogramming in mononuclear phagocytes downstream of stimulation with inflammatory signals (such as LPS and IFNγ) vs alternative activation signals (IL-4), with an emphasis on work on dendritic cells and macrophages from our laboratory, and related studies from others. We cover aspects of glycolysis and its branching pathways (glycogen synthesis, pentose phosphate, serine synthesis, hexose synthesis, and glycerol 3 phosphate shuttle), the tricarboxylic acid pathway, fatty acid synthesis and oxidation, and mitochondrial biology. Although our understanding of the metabolism of mononuclear phagocytes has progressed significantly over the last 10 years, major challenges remain, including understanding the effects of tissue residence on metabolic programming related to cellular activation, and the translatability of findings from mouse to human biology.
Asunto(s)
Sistema Mononuclear Fagocítico/inmunología , Sistema Mononuclear Fagocítico/metabolismo , Fagocitos/inmunología , Fagocitos/metabolismo , Animales , Metabolismo Energético , Humanos , Activación de Macrófagos/genética , Activación de Macrófagos/inmunología , Macrófagos/citología , Macrófagos/inmunología , Macrófagos/metabolismo , Sistema Mononuclear Fagocítico/citología , Fagocitos/citologíaRESUMEN
Immunoimaging is a rapidly growing field stoked in large part by the intriguing triumphs of immunotherapy. On the heels of immunotherapy's successes, there exists a growing need to evaluate tumor response to therapy particularly immunotherapy, stratify patients into responders vs. non-responders, identify inflammation, and better understand the fundamental roles of immune system components to improve both immunoimaging and immunotherapy. Innovative nanomaterials have begun to provide novel opportunities for immunoimaging, in part due to their sensitivity, modularity, capacity for many potentially varied ligands (high avidity), and potential for multifunctionality/multimodality imaging. This review strives to comprehensively summarize the integration of nanotechnology and immunoimaging, and the field's potential for clinical applications.
Asunto(s)
Diagnóstico por Imagen/métodos , Técnicas Inmunológicas/métodos , Nanoestructuras/química , Secuencia de Aminoácidos , Animales , Línea Celular Tumoral , Humanos , Inflamación/diagnóstico por imagen , Leucocitos/citología , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/diagnóstico por imagen , Medicina de Precisión/métodosRESUMEN
The intestinal tract is home to trillions of microbes that make up the gut microbiota and is a major source of environmental antigens that can be derived from food, commensal microorganisms, and potential pathogens. Amidst this complex environment, myeloid cells, including macrophages (MPs) and dendritic cells (DCs), are key immunological sentinels that locally maintain both tissue and immune homeostasis. Recent research has revealed substantial functional and developmental heterogeneity within the intestinal DC and MP compartments, with evidence pointing to their regulation by the microbiota. DCs are classically divided into three subsets based on their CD103 and CD11b expression: CD103+CD11b-(XCR1+) cDC1s, CD103+CD11b+ cDC2s, and CD103-CD11b+ cDC2s. Meanwhile, mature gut MPs have recently been classified by their expression of Tim-4 and CD4 into a long-lived, self-maintaining Tim-4+CD4+ population and short-lived, monocyte-derived Tim-4-CD4+ and Tim-4-CD4- populations. In this chapter, we provide experimental procedures to classify and isolate these myeloid subsets from the murine intestinal lamina propria for functional characterization.
Asunto(s)
Separación Celular/métodos , Citometría de Flujo/métodos , Intestinos/citología , Sistema Mononuclear Fagocítico/citología , Fagocitos/citología , Animales , Antígenos CD/análisis , Antígenos CD/inmunología , Células Dendríticas/citología , Células Dendríticas/inmunología , Femenino , Microbioma Gastrointestinal , Intestinos/inmunología , Macrófagos/citología , Macrófagos/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL , Monocitos/citología , Monocitos/inmunología , Sistema Mononuclear Fagocítico/inmunología , Células Mieloides/inmunología , Fagocitos/inmunología , Coloración y Etiquetado/métodosRESUMEN
Due to their ability to present foreign antigens and prime naïve T cells, macrophages, and dendritic cells (DCs) are referred to as professional antigen-presenting cells (APCs). Although activated macrophages may function as APCs, these cells are particularly effective at directly engaging pathogens through phagocytosis, and production of antimicrobial compounds. On the other hand, DCs possess superb antigen-presenting and costimulatory capacity and they are essential for commencement and regulation of adaptive immune responses. In in vitro models, development of mature mammalian DCs from monocytes requires sequential exposure to growth factors (including GM-CSF and IL-4) and proinflammatory stimuli such as toll-like receptor (TLR) ligands. Currently, except for IL-4/13, neither orthologs nor functional analogs of the growth factors which are essential for the differentiation of mammalian DCs (including GM-CSF and FLT3) have been identified in teleosts and data about differentiation of piscine APCs is scant. In the present study, primary salmon mononuclear phagocytes (MPs) stimulated in vitro for 5-7 days with a B-class CpG oligodeoxynucleotides (ODN 2006PS) underwent morphological differentiation and developed "dendritic" morphology, characterized by long, branching pseudopodia. Transcriptional profiling showed that these cells expressed high levels of proinflammatory mediators characteristic for M1 polarized MPs. However, the cells treated with CpGs for 7 days downregulated their surface MHCII molecules as well as their capacity to endocytose ovalbumin and exhibited attenuated allostimulatory activity. This concurred with transcriptional downregulation of costimulatory CD80/86 and upregulation of inhibitory CD274 (B7-H1) genes. Despite their exhausted allostimulatory activity, these cells were still responsive to re-stimulation with gardiquimod (a TLR7/8 ligand) and further upregulated a wide array of immune genes including proinflammatory mediators such as intereukin-1 beta and tumor necrosis factor. Overall, the presented data highlight the disparate effects TLR ligands may have on the proinflammatory status of APCs, on one side, and their antigen-presenting/costimulatory functions, on the other. These findings also indicate that despite the poor phylogenetic conservation of the growth factors involved in the differentiation of DCs, some of the processes that orchestrate the development and the differentiation of professional APCs are conserved between teleosts in mammals.
Asunto(s)
Diferenciación Celular/inmunología , Dendritas , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/metabolismo , Oligodesoxirribonucleótidos/inmunología , Salmo salar/genética , Salmo salar/inmunología , Transcriptoma , Animales , Biomarcadores , Células Cultivadas , Perfilación de la Expresión Génica , Mediadores de Inflamación , Sistema Mononuclear Fagocítico/inmunología , Fagocitosis/genética , Fagocitosis/inmunología , Salmo salar/metabolismoRESUMEN
Autosomal recessive CARD9 deficiency underlies life-threatening, invasive fungal infections in otherwise healthy individuals normally resistant to other infectious agents. In less than 10 years, 58 patients from 39 kindreds have been reported in 14 countries from four continents. The patients are homozygous (n = 49; 31 kindreds) or compound heterozygous (n = 9; 8 kindreds) for 22 different CARD9 mutations. Six mutations are recurrent, probably due to founder effects. Paradoxically, none of the mutant alleles has been experimentally demonstrated to be loss-of-function. CARD9 is expressed principally in myeloid cells, downstream from C-type lectin receptors that can recognize fungal components. Patients with CARD9 deficiency present impaired cytokine and chemokine production by macrophages, dendritic cells, and peripheral blood mononuclear cells and defective killing of some fungi by neutrophils in vitro. Neutrophil recruitment to sites of infection is impaired in vivo. The proportion of Th17 cells is low in most, but not all, patients tested. Up to 52 patients suffering from invasive fungal diseases (IFD) have been reported, with ages at onset of 3.5 to 52 years. Twenty of these patients also displayed superficial fungal infections. Six patients had only mucocutaneous candidiasis or superficial dermatophytosis at their last follow-up visit, at the age of 19 to 50 years. Remarkably, for 50 of the 52 patients with IFD, a single fungus was involved; only two patients had IFDs due to two different fungi. IFD recurred in 44 of 45 patients who responded to treatment, and a different fungal infection occurred in the remaining patient. Ten patients died from IFD, between the ages of 12 and 39 years, whereas another patient died at the age of 91 years, from an unrelated cause. At the most recent scheduled follow-up visit, 81% of the patients were still alive and aged from 6.5 to 75 years. Strikingly, all the causal fungi belonged to the phylum Ascomycota: commensal Candida and saprophytic Trychophyton, Aspergillus, Phialophora, Exophiala, Corynesprora, Aureobasidium, and Ochroconis. Human CARD9 is essential for protective systemic immunity to a subset of fungi from this phylum but seems to be otherwise redundant. Previously healthy patients with unexplained invasive fungal infection, at any age, should be tested for inherited CARD9 deficiency. KEY POINTS: ⢠Inherited CARD9 deficiency (OMIM #212050) is an AR PID due to mutations that may be present in a homozygous or compound heterozygous state. ⢠CARD9 is expressed principally in myeloid cells and transduces signals downstream from CLR activation by fungal ligands. ⢠Endogenous mutant CARD9 levels differ between alleles (from full-length normal protein to an absence of normal protein). ⢠The functional impacts of CARD9 mutations involve impaired cytokine production in response to fungal ligands, impaired neutrophil killing and/or recruitment to infection sites, and defects of Th17 immunity. ⢠The key clinical manifestations in patients are fungal infections, including CMC, invasive (in the CNS in particular) Candida infections, extensive/deep dermatophytosis, subcutaneous and invasive phaeohyphomycosis, and extrapulmonary aspergillosis. ⢠The clinical penetrance of CARD9 deficiency is complete, but penetrance is incomplete for each of the fungi concerned. ⢠Age at onset is highly heterogeneous, ranging from childhood to adulthood for the same fungal disease. ⢠All patients with unexplained IFD should be tested for CARD9 mutations. Familial screening and genetic counseling should be proposed. ⢠The treatment of patients with CARD9 mutations is empirical and based on antifungal therapies and the surgical removal of fungal masses. Patients with persistent/relapsing Candida infections of the CNS could be considered for adjuvant GM-CSF/G-CSF therapy. The potential value of HSCT for CARD9-deficient patients remains unclear.
Asunto(s)
Candidiasis Mucocutánea Crónica/diagnóstico , Candidiasis Mucocutánea Crónica/etiología , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Adulto , Alelos , Animales , Proteínas Adaptadoras de Señalización CARD/genética , Proteínas Adaptadoras de Señalización CARD/metabolismo , Candidiasis Mucocutánea Crónica/epidemiología , Candidiasis Mucocutánea Crónica/terapia , Niño , Biología Computacional/métodos , Modelos Animales de Enfermedad , Expresión Génica , Regulación de la Expresión Génica , Frecuencia de los Genes , Estudios de Asociación Genética/métodos , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Inmunidad , Ratones , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/inmunología , Sistema Mononuclear Fagocítico/metabolismo , Mutación , FenotipoRESUMEN
Sepsis, in essence, is a serious clinical condition that can subsequently result in death as a consequence of a systemic inflammatory response syndrome including febrile leukopenia, hypotension, and multiple organ failures. To date, such life-threatening organ dysfunction remains one of the leading causes of death in intensive care units, with an increasing incidence rate worldwide and particularly within the rapidly growing senior population. While most of the clinical trials are aimed at dampening the overwhelming immune response to infection that spreads through the bloodstream, based on several human immunological investigations, it is now widely accepted that susceptibility to nosocomial infections and long-term sepsis mortality involves an immunosuppressive phase that is characterized by a decrease in some subsets of dendritic cells (DCs). Only recently substantial advances have been made in terms of the origin of the mononuclear phagocyte system that is now likely to allow for a better understanding of how the paralysis of DCs leads to sepsis-related death. Indeed, the unifying view of each subset of DCs has already improved our understanding of the pivotal pathways that contribute to the shift in commitment of their progenitors that originate from the bone marrow. It is quite plausible that this anomaly in sepsis may occur at the single level of DC-committed precursors, and elucidating the immunological basis for such a derangement during the ontogeny of each subset of DCs is now of particular importance for restoring an adequate cell fate decision to their vulnerable progenitors. Last but not least, it provides a direct perspective on the development of sophisticated myelopoiesis-based strategies that are currently being considered for the treatment of immunosenescence within different tissue microenvironments, such as the kidney and the spleen.
Asunto(s)
Células Dendríticas/inmunología , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/inmunología , Sepsis/inmunología , Animales , Diferenciación Celular/inmunología , Microambiente Celular , Células Dendríticas/patología , Modelos Animales de Enfermedad , Humanos , Ratones , Mielopoyesis , Sepsis/patologíaRESUMEN
The kidney contains a large and complex network of mononuclear phagocytes, which includes dendritic cells (DCs) and macrophages (MØs). The distinction between these cell types is traditionally based on the expression of molecular markers and morphology. However, several classification systems are used in parallel to identify DCs and MØs, leading to considerable uncertainty about their identity and functional roles. The discovery that a substantial proportion of macrophages in tissues like the kidney are embryonically derived further complicates the situation. Recent studies have used newly identified transcription factors such as ZBTB46 and lineage tracing techniques for classifying mononuclear phagocytes. These approaches have shed new light on the functional specialization of these cells in health and disease, uncovered an influence of the renal microenvironment and revealed considerable cellular plasticity, especially in inflammatory situations. In this review, the current knowledge about the developmental origins and versatile functional roles of DCs and MØs in kidney homeostasis and disease is discussed.
Asunto(s)
Células Dendríticas/inmunología , Riñón/inmunología , Macrófagos/inmunología , Sistema Mononuclear Fagocítico/inmunología , Animales , Diferenciación Celular/inmunología , Células Dendríticas/citología , Células Dendríticas/metabolismo , Homeostasis/inmunología , Humanos , Riñón/citología , Riñón/metabolismo , Enfermedades Renales/inmunología , Enfermedades Renales/metabolismo , Macrófagos/citología , Macrófagos/metabolismo , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/metabolismo , Factores de Transcripción/inmunología , Factores de Transcripción/metabolismoRESUMEN
The application of nanotechnology in the treatment of tumors has boomed owing to the vigorous development in cancer nanomedicine. Despite the great success achieved in this field, nanomedicine has not realized its full potential owing to a delivery barrier, the mononuclear phagocytic system (MPS), which cuts off more than 95 % of the administrated nanoparticles. This results in an extremely low drug-delivery efficacy to the tumor and leads to poor therapeutic outcomes. Moreover, the injection of excess nanoparticles also raises toxicity concerns induced by the accumulation of nanomaterials in organs, such as the liver and spleen. Therefore, a reduction in the uptake of nanomedicines by the MPS is vital to enhance the cancer therapeutic effect and decrease side effects. In this critical review, we will summarize the new strategies to reduce nanoparticle uptake by the MPS based on current knowledge of the bio-nano interaction. Further directions will also be highlighted for the development of cancer nanomedicine with a lower off-target rate and better therapeutic outcomes.
Asunto(s)
Sistema Mononuclear Fagocítico/metabolismo , Nanomedicina , Nanopartículas/química , Neoplasias/patología , Materiales Biocompatibles/química , Materiales Biocompatibles/metabolismo , Portadores de Fármacos/química , Humanos , Sistema Mononuclear Fagocítico/citología , Nanopartículas/metabolismo , Nanopartículas/uso terapéutico , Neoplasias/tratamiento farmacológico , Polímeros/químicaRESUMEN
In mammals, macrophages (MF) are present in virtually all tissues where they serve many different functions linked primarily to the maintenance of homeostasis, innate defense against pathogens, tissue repair and metabolism. Although some of these functions appear common to all tissues, others are specific to the homing tissue. Thus, MF become adapted to perform particular functions in a given tissue. Accordingly, MF express common markers but also sets of tissue-specific markers linked to dedicated functions. One of the largest pool of MF in the body lines up the wall of the gut. Located in the small intestine, Peyer's patches (PP) are primary antigen sampling and mucosal immune response inductive sites. Surprisingly, although markers of intestinal MF, such as F4/80, have been identified more than 30â¯years ago, MF of PP escaped any kind of phenotypic description and remained "unknown" for decades. In absence of MF identification, the characterization of the PP mononuclear phagocyte system (MPS) functions has been impaired. However, taking into account that PP are privileged sites of entry for pathogens, it is important to understand how the latter are handled by and/or escape the PP MPS, especially MF, which role in killing invaders is well known. This review focuses on recent advances on the PP MPS, which have allowed, through new criteria of PP phagocyte subset identification, the characterization of PP MF origin, diversity, specificity, location and functions.
Asunto(s)
Mucosa Intestinal/inmunología , Intestino Delgado/inmunología , Macrófagos/inmunología , Sistema Mononuclear Fagocítico/inmunología , Ganglios Linfáticos Agregados/inmunología , Inmunidad Adaptativa/inmunología , Animales , Inmunidad Mucosa/inmunología , Sistema Mononuclear Fagocítico/citología , Ganglios Linfáticos Agregados/citología , Fagocitos/inmunologíaRESUMEN
Monocytes, dendritic cells (DCs) and macrophages have been classically categorized into the mononuclear phagocyte system (MPS) based on their similar functional and phenotypic characteristics. While an increasing amount of research has revealed substantial ontogenic and functional differences among these cells, the reasons behind their heterogeneity and strategic positioning in specific niches throughout the body are yet to be fully elucidated. In this review, we outline how recent advances in intravital imaging studies have dissected this phenomenon and have allowed us to appreciate how MPS cells exploit their regional niches to specialize and maximize their functional properties. Understanding their cellular behavior in each of their specialized microenvironment will eventually allow us to target specific cells and their behavioral patterns for improved vaccine and therapeutic purposes.
Asunto(s)
Monocitos/inmunología , Monocitos/metabolismo , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/fisiología , Fagocitos/inmunología , Fagocitos/metabolismo , Animales , Microambiente Celular/inmunología , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Humanos , Macrófagos/inmunología , Macrófagos/metabolismoRESUMEN
Mitochondria are important signalling organelles, and they dictate immunological fate. From T cells to macrophages, mitochondria form the nexus of the various metabolic pathways that define each immune cell subset. In this central position, mitochondria help to control the various metabolic decision points that determine immune cell function. In this Review, we discuss how mitochondrial metabolism varies across different immune cell subsets, how metabolic signalling dictates cell fate and how this signalling could potentially be targeted therapeutically.
Asunto(s)
Linfocitos/inmunología , Linfocitos/metabolismo , Redes y Vías Metabólicas , Mitocondrias/metabolismo , Sistema Mononuclear Fagocítico/inmunología , Inmunidad Adaptativa , Animales , Humanos , Inmunidad Innata , Linfocitos/citología , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/metabolismoRESUMEN
Neutrophils are first responders of the immune system, rapidly migrating into affected tissues in response to injury or infection. To effectively call in this first line of defense, strategically placed cells within the vasculature and tissue respond to noxious stimuli by sending out coordinated signals that recruit neutrophils. Regulation of organ-specific neutrophil entry occurs at two levels. First, the vasculature supplying the organ provides cues for neutrophil egress out of the bloodstream in a manner dependent upon its unique cellular composition and architectural features. Second, resident immune cells and stromal cells within the organ send coordinated signals that guide neutrophils to their final destination. Here, we review recent findings that highlight the importance of these tissue-specific responses in the regulation of neutrophil recruitment and the initiation and resolution of inflammation.
Asunto(s)
Infiltración Neutrófila/inmunología , Neutrófilos/inmunología , Animales , Vasos Sanguíneos/inmunología , Vasos Sanguíneos/metabolismo , Quimiotaxis de Leucocito/inmunología , Endotelio Vascular/metabolismo , Humanos , Inmunidad Innata , Inmunomodulación , Inflamación/inmunología , Inflamación/metabolismo , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/inmunología , Sistema Mononuclear Fagocítico/metabolismo , Neutrófilos/metabolismo , Especificidad de Órganos/inmunología , Pericitos/metabolismoRESUMEN
The human mononuclear phagocyte network comprises dendritic cells (DCs), monocytes and macrophages with a range of immune functions including antigen presentation linking innate and adaptive immunity. A number of DC, monocyte and macrophage subsets have been described in lymphoid and non-lymphoid tissues of mouse and human, with increased understanding of their distinct functional properties and genetic and cellular pathways of development. More recently, through comparative biology studies, a unified nomenclature of mononuclear phagocytes has begun to emerge with the identification of homologous subsets in several species. In this review, we discuss the current classification of human mononuclear phagocytes and the parallel organization of this network in the mouse. We also review the genetic control and developmental pathway of human mononuclear phagocytes and the immunological functions of the distinct subsets in health and inflammation.
Asunto(s)
Macrófagos/inmunología , Monocitos/inmunología , Sistema Mononuclear Fagocítico/inmunología , Inmunidad Adaptativa/inmunología , Animales , Diferenciación Celular/inmunología , Células Dendríticas/citología , Células Dendríticas/inmunología , Humanos , Macrófagos/citología , Ratones , Modelos Inmunológicos , Monocitos/citología , Sistema Mononuclear Fagocítico/citologíaRESUMEN
Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB), is an intracellular pathogen of mononuclear phagocytes. Although M. tuberculosis has traditionally been thought to survive and replicate in macrophages, recent work in our laboratory and others has revealed that M. tuberculosis infects multiple subsets of mononuclear phagocytes in vivo and in vitro. In experimental animals, M. tuberculosis infects no fewer than five distinct cell subsets in the lungs, including resident alveolar macrophages and 4 types of cells that recruited to the lungs in response to inflammatory signals: neutrophils, monocytes, interstitial macrophages, and dendritic cells. A characteristic of the adaptive immune response in TB is that it is delayed for several weeks following infection, and we have determined that this delay is due to prolonged residence of the bacteria in lung phagocytes prior to acquisition of the bacteria by dendritic cells. Among the mechanisms used by M. tuberculosis to delay acquisition by dendritic cells is to inhibit apoptosis of alveolar macrophages and neutrophils, which sequester the bacteria and prevent their acquisition by dendritic cells in the early stages of infection. We hypothesize that each infected cell subset makes a distinct contribution to the overall biology of M. tuberculosis and allows the bacteria to evade elimination by T-cell responses and to avoid rapid killing by antimycobacterial drugs.
Asunto(s)
Macrófagos/inmunología , Macrófagos/metabolismo , Sistema Mononuclear Fagocítico/inmunología , Sistema Mononuclear Fagocítico/metabolismo , Tuberculosis/etiología , Tuberculosis/patología , Inmunidad Adaptativa , Animales , Diferenciación Celular , Movimiento Celular , Células Dendríticas/citología , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Humanos , Inmunidad Innata , Macrófagos/citología , Macrófagos/patología , Macrófagos Alveolares/citología , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/patología , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/patología , Neutrófilos/inmunología , Neutrófilos/metabolismo , FenotipoRESUMEN
Tissues that are in direct contact with the outside world face particular immunological challenges. The intestine, the skin, and the lung possess important mononuclear phagocyte populations to deal with these challenges, but the cellular origin of these phagocytes is strikingly different from one subset to another, with some cells derived from embryonic precursors and some from bone marrow-derived circulating monocytes. Here, we review the current knowledge regarding the developmental pathways that control the differentiation of mononuclear phagocytes in these barrier tissues. We have also attempted to build a theoretical model that could explain the distinct cellular origin of mononuclear phagocytes in these tissues.
Asunto(s)
Intestinos/fisiología , Pulmón/fisiología , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/fisiología , Fenómenos Fisiológicos de la Piel , Animales , Diferenciación Celular , Movimiento Celular , Microambiente Celular , Humanos , Modelos Biológicos , Especificidad de ÓrganosRESUMEN
Monocytes and macrophages differentiate from progenitor cells under the influence of colony-stimulating factors. Genome-scale data have enabled the identification of the sets of genes that are associated with specific functions and the mechanisms by which thousands of genes are regulated in response to pathogen challenge. In large datasets, it is possible to identify large sets of genes that are coregulated with the transcription factors that regulate them. They include macrophage-specific genes, interferon-responsive genes, early inflammatory genes, and those associated with endocytosis. Such analyses can also extract macrophage-associated signatures from large cancer tissue datasets. However, cluster analysis provides no support for a signature that distinguishes macrophages from antigen-presenting dendritic cells, nor the classification of macrophage activation states as classical versus alternative, or M1 versus M2. Although there has been a focus on a small subset of lineage-enriched transcription factors, such as PU.1, more than half of the transcription factors in the genome can be expressed in macrophage lineage cells under some state of activation, and they interact in a complex network. The network architecture is conserved across species, but many of the target genes evolve rapidly and differ between mouse and human. The data and publication deluge related to macrophage biology require the development of new analytical tools and ways of presenting information in an accessible form.
Asunto(s)
Diferenciación Celular , Activación de Macrófagos , Sistema Mononuclear Fagocítico/citología , Sistema Mononuclear Fagocítico/fisiología , Transcriptoma , Animales , Bases de Datos Factuales , Células Dendríticas/citología , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Redes Reguladoras de Genes , Genómica , Humanos , Macrófagos/citología , Macrófagos/inmunología , Macrófagos/metabolismo , Monocitos/citología , Monocitos/inmunología , Monocitos/metabolismo , Especificidad de Órganos , Transducción de Señal , Navegador WebRESUMEN
The mononuclear phagocyte system (MPS) has historically been categorized into monocytes, dendritic cells and macrophages on the basis of functional and phenotypical characteristics. However, considering that these characteristics are often overlapping, the distinction between and classification of these cell types has been challenging. In this Opinion article, we propose a unified nomenclature for the MPS. We suggest that these cells can be classified primarily by their ontogeny and secondarily by their location, function and phenotype. We believe that this system permits a more robust classification during both steady-state and inflammatory conditions, with the benefit of spanning different tissues and across species.
Asunto(s)
Células Dendríticas/clasificación , Macrófagos/clasificación , Monocitos/clasificación , Sistema Mononuclear Fagocítico/citología , Terminología como Asunto , Animales , Diferenciación Celular/inmunología , Células Dendríticas/inmunología , Humanos , Macrófagos/inmunología , Ratones , Monocitos/inmunología , FagocitosisRESUMEN
Dendritic cells (DCs) are a heterogeneous group of functionally specialized antigen-presenting cells that initiate and orchestrate immune responses. Our understanding of DC immunobiology has been largely shaped by research using murine models. The relevance of murine findings on human DC organization and function is only just beginning to be investigated. In this chapter, we present the key historical developments and recent advances in human and mouse DC research to contextualize the existing knowledge on DC subset origin and functional specializations. We also propose a framework to align human and mouse DC networks to enhance our understanding of the parallel organization of DCs in both species in order to facilitate the full exploitation of our knowledge on DC biology and function for clinical therapeutic strategies.